Back to
BNP PARIBAS FINANCIAL MARKETS
SGMOQ31 quarters
Position history for
BNP PARIBAS FINANCIAL MARKETS's holdings in SANGAMO THERAPEUTICS, INC
As of its Q1 2026 13F, BNP Paribas Financial Markets held 266 shares of SGMOQ (Sangamo Therapeutics), worth $66. BNP Paribas Financial Markets' 13F filings listed SGMOQ from Q4 2018 to Q1 2026, 30 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$12,433
Total Shares Change
-1,083
Quarter-by-Quarter History
Other major holders of SGMOQ: WASATCH ADVISORS LP, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP